The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk
- PMID: 16227801
- DOI: 10.1097/01.aids.0000188428.33280.41
The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk
Abstract
Viral load and drug levels were measured in the plasma and breast milk of nine mothers treated with highly active antiretroviral therapy (HAART) and one woman treated only with zidovudine during delivery. In all HAART-treated women after delivery the viral load was less than 400 copies/ml in plasma and breast milk. Compared with the plasma concentration, the breast milk concentration was between 68 and 90% for nevirapine, 6 and 24% for nelfinavir and 90 and 540% for indinavir.
Similar articles
-
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):286-91. doi: 10.1097/QAI.0b013e31802c5441. J Acquir Immune Defic Syndr. 2007. PMID: 17146372 Clinical Trial.
-
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.Antivir Ther. 2008;13(6):799-807. Antivir Ther. 2008. PMID: 18839781 Free PMC article. Clinical Trial.
-
Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.J Infect Dis. 2005 Sep 1;192(5):713-9. doi: 10.1086/432489. Epub 2005 Jul 27. J Infect Dis. 2005. PMID: 16088820 Clinical Trial.
-
Antiretroviral interventions for preventing breast milk transmission of HIV.Cochrane Database Syst Rev. 2014 Oct 4;(10):CD011323. doi: 10.1002/14651858.CD011323. Cochrane Database Syst Rev. 2014. PMID: 25280769 Review.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
Cited by
-
Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding.Microbiome. 2022 Apr 12;10(1):61. doi: 10.1186/s40168-022-01230-1. Microbiome. 2022. PMID: 35414043 Free PMC article.
-
Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.Bioanalysis. 2018 Nov 19:10.4155/bio-2018-0085. doi: 10.4155/bio-2018-0085. Online ahead of print. Bioanalysis. 2018. PMID: 30450920 Free PMC article.
-
Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies.J Antimicrob Chemother. 2015 Jul;70(7):1928-41. doi: 10.1093/jac/dkv080. Epub 2015 Apr 8. J Antimicrob Chemother. 2015. PMID: 25858354 Free PMC article. Review.
-
Antiretroviral bioanalysis methods of tissues and body biofluids.Bioanalysis. 2013 Feb;5(3):351-68. doi: 10.4155/bio.12.319. Bioanalysis. 2013. PMID: 23394701 Free PMC article. Review.
-
Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):462-5. doi: 10.1097/QAI.0b013e31825ddcfa. J Acquir Immune Defic Syndr. 2012. PMID: 22614899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
